Moreover, treated with triptolide resulted in a significant reduction in the protein expression of CD47 and CD126 in the THP-1 macrophage cell line and the KG-1 erythroleukemia cell line, with the fold changes for CD47 were 0.3 (THP-1) and 0.55 (KG-1) in vitro [985]. This evidence concerns the gene CD47 and erythroleukemia.